{"schema_version":"secwatch.filing_event.v1","accession":"0001472375-22-000082","form_type":"8-K","ticker":"RGPX","cik":"0001357878","company_name":"REGENEREX PHARMA, INC.","filed_at":"2022-08-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.504749+00:00","generated_at":"2026-06-23T20:53:38.468382+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Regenerex Pharma announces CFO, director resignations; appoints Lee Ori to board, Deborah Pilant as CFO","bullets":["Irene Getty resigned as CFO, Bruce Sellars resigned from board, Byron Striloff resigned as officer, all effective Aug 25, 2022.","Dr. Lee Ori appointed to board effective Aug 25; he also serves as COO. Background: pharmacy doctorate, Eli Lilly, multiple pharmacist licenses.","Deborah L. Pilant appointed CFO effective Aug 25; already serving as Secretary/Treasurer and Director. Background in education, construction, sales.","No reason given for departures or any financial impact disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001472375-22-000082","json":"https://secwatch.observer/filing/0001472375-22-000082.json","markdown":"https://secwatch.observer/filing/0001472375-22-000082.md","text":"https://secwatch.observer/filing/0001472375-22-000082.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357878/000147237522000082/0001472375-22-000082-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357878/000147237522000082/ixform8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T20:53:38.468382+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2096ca73bc","claim":"Irene Getty resigned as Chief Financial Officer at REGENEREX PHARMA, INC..","evidence_excerpt":"Effective August 25, 2022, Irene Getty tendered her letter of resignation to the Company resigning from her positions as Chief Financial Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1357878/000147237522000082/0001472375-22-000082-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"3d32c6a75a","claim":"Bruce Sellars resigned as Director at REGENEREX PHARMA, INC..","evidence_excerpt":"Effective August 25, 2022, Bruce Sellars tendered his letter of resignation to the Company resigning from his position as a member of the Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1357878/000147237522000082/0001472375-22-000082-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"41d4416bca","claim":"Deborah L. Pilant was appointed as Chief Financial Officer at REGENEREX PHARMA, INC..","evidence_excerpt":"Effective August 25, 2022, Deborah L. Pilant has been appointed to serve as Chief Financial Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1357878/000147237522000082/0001472375-22-000082-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"b62923e535","claim":"Byron Striloff resigned as other_named_officer at REGENEREX PHARMA, INC..","evidence_excerpt":"Effective August 25, 2022, Byron Striloff tendered his letter of resignation to the Company resigning from his position as an Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1357878/000147237522000082/0001472375-22-000082-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"}],"fact_type":"executive_change"},{"claim_id":"ec4c910162","claim":"Dr. Lee Ori was appointed as Director at REGENEREX PHARMA, INC..","evidence_excerpt":"Effective August 25, 2022, Dr Lee Ori has been elected/appointed to the Board of Directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1357878/000147237522000082/0001472375-22-000082-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}